Convergence Investment Partners, LLC Alkermes Plc. Transaction History
Convergence Investment Partners, LLC
- $261 Million
- Q1 2024
A detailed history of Convergence Investment Partners, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 20,068 shares of ALKS stock, worth $487,451. This represents 0.21% of its overall portfolio holdings.
Number of Shares
20,068Holding current value
$487,451% of portfolio
0.21%Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
356Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$709 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$490 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$362 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$219 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$202 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.99B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...